Early-onset epilepsy and inborn errors of metabolism: A large retrospective pediatric cohort.
文献摘要
Background Inborn errors of metabolism (IEM) are an under-recognised cause of childhood epilepsy. Early diagnosis is critical because specific treatments can substantially alter the disease course. Methods We performed a retrospective study on 21,072 children evaluated for epilepsy in two Child Neurology referral centres in Eastern Sicily (i.e. Messina, Catania, and Enna) between January 2001 and December 2025. Medical records were reviewed to identify patients with a confirmed IEM diagnosis. Clinical, electrophysiological, neuroimaging, and treatment data were collected and analysed. Results Fifty-seven children (0.27%) had a co-diagnosis of epilepsy and IEM (28 males, 29 females). Lysosomal storage disorders were the most common category (31.6%), followed by aminoacidopathies (22.8%), mitochondrial disorders (15.8%), congenital disorders of glycosylation (CDG, 12.3%), and organic acidaemias (7.0%). Seizure onset occurred before the age of three years in 83.3% of IEM cases, compared with 27.6% of children with non-metabolic epilepsy (OR 12.3; 95% CI 6.2-24.4; p Conclusions IEM should be systematically considered in any child presenting with epilepsy, particularly when onset occurs in the first three years of life. A structured stepwise diagnostic approach can substantially reduce diagnostic delay and facilitate access to disease-specific therapies.